Canine pancreatitis injectable lands U.S. distributionMay 18, 2023Panoquell-CA1’s active ingredient, fuzapladib sodium, has been approved for canine use in Japan since 2018.
SPONSORED CONTENTUncompromising renal + sensitivities care.Help manage sensitivities + chronic kidney disease with the power of Prescription Diet k/d + z/d Hydrolyzed. + Learn More